Masazumi Nagai

Masazumi Nagai is a seasoned scientist in the field of biochemistry and dentistry, currently serving as Principal Lead Scientist at Northway Biotech since October 2022 and as a Senior Investigator at AB Biosciences since April 2022. Masazumi Nagai has held multiple academic roles, including Visiting Professor at Iwate Medical University and Lecturer in Oral Medicine Infection and Immunity at Harvard School of Dental Medicine. Additionally, previous positions include Principal Scientist at Northway Biotech, Senior Scientist at QLB Biotherapeutics, and Scientist at Abpro Therapeutics. Masazumi Nagai's extensive experience in the pharmaceutical and biotechnology industries began in 2003 at Synta Pharmaceuticals. The academic background includes a Doctor of Philosophy (Ph.D.) in Dentistry/Biochemistry from Harvard School of Dental Medicine and undergraduate studies at Iwate Medical University.